| (USD) | Sep 2025 | Y/Y change |
|---|---|---|
| Revenue | 5.44M | — |
| Operating expense | — | — |
| Net income | -7.38M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, SPRO returned -33.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -47.0% |
| 1 year | -33.2% |
| 5 years | -93.6% |
| All-time high | $19.39 (Dec 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in SPRO would be worth today ›No. Spero Therapeutics, Inc. has not paid a dividend in the past 12 months.
Spero Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol SPRO.
Spero Therapeutics, Inc. is part of the Healthcare sector.
Spero Therapeutics, Inc. has a market cap of 71.92M USD, based on the latest quote.
Spero Therapeutics, Inc. is scheduled to report earnings on Nov 12, 2026.
